Mountzios G, de Toma A, Economopoulou P, Friedlaender A, et al. Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy. Clin Lung Cancer 2021;22:e180-e192.
PMID: 33162330